ITRM920349A0 - Composizioni farmaceutiche contenenti il-6 - Google Patents
Composizioni farmaceutiche contenenti il-6Info
- Publication number
- ITRM920349A0 ITRM920349A0 IT92RM349A ITRM920349A ITRM920349A0 IT RM920349 A0 ITRM920349 A0 IT RM920349A0 IT 92RM349 A IT92RM349 A IT 92RM349A IT RM920349 A ITRM920349 A IT RM920349A IT RM920349 A0 ITRM920349 A0 IT RM920349A0
- Authority
- IT
- Italy
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- compositions
- Prior art date
Links
- 108090001005 Interleukin-6 Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM920349A IT1254359B (it) | 1992-05-11 | 1992-05-11 | Composizioni farmaceutiche contenenti il-6 |
| US08/335,874 US5635176A (en) | 1992-05-11 | 1993-05-07 | Pharmaceutical compositions containing IL-6 |
| AT93909917T ATE157256T1 (de) | 1992-05-11 | 1993-05-07 | Il-6 enthaltende pharmazeutische zusammensetzungen stabilisiert mit einem nicht- reduzierenden zucker |
| DK93909917.2T DK0641216T3 (da) | 1992-05-11 | 1993-05-07 | Farmaceutisk præparat indeholdende IL-6 |
| ES93909917T ES2105257T3 (es) | 1992-05-11 | 1993-05-07 | Composiciones farmaceuticas que contienen il-6 estabilizadas con un azucar no reductor. |
| JP51984193A JP3714951B2 (ja) | 1992-05-11 | 1993-05-07 | Ｉｌ−６含有薬剤組成物 |
| DE69313444T DE69313444T2 (de) | 1992-05-11 | 1993-05-07 | IL-6 ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN stabilisiert mit einem nicht-reduzierenden Zucker |
| PCT/EP1993/001120 WO1993023065A1 (en) | 1992-05-11 | 1993-05-07 | Pharmaceutical compositions containing il-6 |
| AU40653/93A AU676833B2 (en) | 1992-05-11 | 1993-05-07 | Pharmaceutical compositions containing IL-6 |
| EP93909917A EP0641216B1 (en) | 1992-05-11 | 1993-05-07 | PHARMACEUTICAL COMPOSITIONS CONTAINING IL-6 stabilized with a non-reducing sugar |
| CA002117761A CA2117761C (en) | 1992-05-11 | 1993-05-07 | Pharmaceutical compositions containing il-6 |
| GR970402352T GR3024708T3 (en) | 1992-05-11 | 1997-09-11 | Pharmaceutical compositions containing il-6. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM920349A IT1254359B (it) | 1992-05-11 | 1992-05-11 | Composizioni farmaceutiche contenenti il-6 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITRM920349A0 true ITRM920349A0 (it) | 1992-05-11 |
| ITRM920349A1 ITRM920349A1 (it) | 1993-11-11 |
| IT1254359B IT1254359B (it) | 1995-09-14 |
Family
ID=11400994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITRM920349A IT1254359B (it) | 1992-05-11 | 1992-05-11 | Composizioni farmaceutiche contenenti il-6 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5635176A (it) |
| EP (1) | EP0641216B1 (it) |
| JP (1) | JP3714951B2 (it) |
| AT (1) | ATE157256T1 (it) |
| AU (1) | AU676833B2 (it) |
| CA (1) | CA2117761C (it) |
| DE (1) | DE69313444T2 (it) |
| DK (1) | DK0641216T3 (it) |
| ES (1) | ES2105257T3 (it) |
| GR (1) | GR3024708T3 (it) |
| IT (1) | IT1254359B (it) |
| WO (1) | WO1993023065A1 (it) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000510813A (ja) * | 1995-02-06 | 2000-08-22 | ジェネテイックス・インスティテュート・インコーポレイテッド | Ｉｌ−１２用処方 |
| GB9508691D0 (en) * | 1995-04-28 | 1995-06-14 | Pafra Ltd | Stable compositions |
| US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
| DE19539574A1 (de) | 1995-10-25 | 1997-04-30 | Boehringer Mannheim Gmbh | Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren |
| US5770700A (en) * | 1996-01-25 | 1998-06-23 | Genetics Institute, Inc. | Liquid factor IX formulations |
| US6632648B1 (en) * | 1996-05-14 | 2003-10-14 | Elan Drug Delivery Limited | Methods of terminal sterilization of fibrinogen |
| US7141393B2 (en) * | 1996-12-26 | 2006-11-28 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interleukin-18-receptor proteins |
| US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| US6433760B1 (en) | 1999-01-14 | 2002-08-13 | University Of Central Florida | Head mounted display with eyetracking capability |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| WO2002053136A1 (fr) * | 2000-12-28 | 2002-07-11 | Takeda Chemical Industries, Ltd. | Preparations a liberation soutenue |
| JP2005514393A (ja) | 2001-12-19 | 2005-05-19 | ネクター セラピューティクス | アミノグリコシドの肺への供給 |
| JP4364645B2 (ja) * | 2002-02-14 | 2009-11-18 | 中外製薬株式会社 | 抗体含有溶液製剤 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4457916A (en) * | 1982-08-31 | 1984-07-03 | Asahi Kasei Kogyo Kabushiki Kaisha | Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same |
| WO1987000196A1 (en) * | 1985-07-09 | 1987-01-15 | Quadrant Bioresources Limited | Protection of proteins and the like |
| EP0835661B1 (en) * | 1985-10-14 | 2007-08-29 | Yeda Research And Development Co. Ltd. | Human interferon-Beta2A for use as a medicament |
| US4762857A (en) * | 1986-05-30 | 1988-08-09 | E. I. Du Pont De Nemours And Company | Trehalose as stabilizer and tableting excipient |
| DE3621828A1 (de) * | 1986-06-28 | 1988-01-14 | Biotest Pharma Gmbh | Stabilisierung eines fuer therapeutische zwecke, insbesondere beim menschen, bestimmten interleukin-2-praeparates sowie dieses praeparat enthaltende stabilisierte waessrige loesung oder feststoff |
| US5078997A (en) * | 1988-07-13 | 1992-01-07 | Cetus Corporation | Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers |
| US5104651A (en) * | 1988-12-16 | 1992-04-14 | Amgen Inc. | Stabilized hydrophobic protein formulations of g-csf |
| JP2805224B2 (ja) * | 1989-01-13 | 1998-09-30 | 味の素株式会社 | 血小板減少症治療剤 |
| JPH0327320A (ja) * | 1989-06-26 | 1991-02-05 | Ajinomoto Co Inc | ヒトｂ細胞分化因子医薬組成物 |
| JPH05963A (ja) * | 1990-04-13 | 1993-01-08 | Toray Ind Inc | ポリペプチド類組成物 |
| US5416071A (en) * | 1991-03-12 | 1995-05-16 | Takeda Chemical Industries, Ltd. | Water-soluble composition for sustained-release containing epo and hyaluronic acid |
| EP0560998A4 (en) * | 1991-10-09 | 1993-12-01 | Toray Industries, Inc. | Medicine for preventing and treating bleeding tendency |
| JP3027320U (ja) | 1996-01-27 | 1996-08-09 | 三千男 高橋 | 野球グラブの装着補強具 |
-
1992
- 1992-05-11 IT ITRM920349A patent/IT1254359B/it active
-
1993
- 1993-05-07 AT AT93909917T patent/ATE157256T1/de not_active IP Right Cessation
- 1993-05-07 EP EP93909917A patent/EP0641216B1/en not_active Expired - Lifetime
- 1993-05-07 ES ES93909917T patent/ES2105257T3/es not_active Expired - Lifetime
- 1993-05-07 DE DE69313444T patent/DE69313444T2/de not_active Expired - Fee Related
- 1993-05-07 DK DK93909917.2T patent/DK0641216T3/da active
- 1993-05-07 JP JP51984193A patent/JP3714951B2/ja not_active Expired - Fee Related
- 1993-05-07 US US08/335,874 patent/US5635176A/en not_active Expired - Fee Related
- 1993-05-07 WO PCT/EP1993/001120 patent/WO1993023065A1/en active IP Right Grant
- 1993-05-07 AU AU40653/93A patent/AU676833B2/en not_active Ceased
- 1993-05-07 CA CA002117761A patent/CA2117761C/en not_active Expired - Fee Related
-
1997
- 1997-09-11 GR GR970402352T patent/GR3024708T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2117761C (en) | 2005-10-04 |
| DK0641216T3 (da) | 1998-01-26 |
| AU4065393A (en) | 1993-12-13 |
| EP0641216A1 (en) | 1995-03-08 |
| ATE157256T1 (de) | 1997-09-15 |
| JP3714951B2 (ja) | 2005-11-09 |
| DE69313444T2 (de) | 1998-01-02 |
| US5635176A (en) | 1997-06-03 |
| WO1993023065A1 (en) | 1993-11-25 |
| GR3024708T3 (en) | 1997-12-31 |
| EP0641216B1 (en) | 1997-08-27 |
| ES2105257T3 (es) | 1997-10-16 |
| DE69313444D1 (de) | 1997-10-02 |
| ITRM920349A1 (it) | 1993-11-11 |
| AU676833B2 (en) | 1997-03-27 |
| JPH08502722A (ja) | 1996-03-26 |
| CA2117761A1 (en) | 1993-11-25 |
| IT1254359B (it) | 1995-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT589843E (pt) | Composicoes farmaceuticas contendo ciclosporinas | |
| EE03108B1 (et) | Farmatseutiline kompositsioon | |
| FI981777A0 (fi) | Farmaseuttinen ainekoostumus | |
| DE69313134T2 (de) | Adjuvantien enthaltende impfstoffzusammensetzung | |
| BR9307801A (pt) | Composições orais | |
| NO930543L (no) | Doseringsform | |
| CY2005007I1 (el) | Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη | |
| NO179941C (no) | Farmasöytisk forbindelse | |
| ITRM910952A0 (it) | Composizioni farmaceutiche contenenti gonadotropine | |
| MX9200622A (es) | Composicion farmaceutica | |
| ITRM920349A0 (it) | Composizioni farmaceutiche contenenti il-6 | |
| NO934145L (no) | Farmasöytiske forbindelser | |
| FI931251A0 (fi) | Farmaceutiska foereningar | |
| BR9307800A (pt) | ComposiçÕes anticárie | |
| IT1290797B1 (it) | Composizioni farmaceutiche stabilizzate | |
| ITMI950961A0 (it) | Composizioni farmaceutiche contenenti gemfibrozil | |
| FI952377A (fi) | Farmaseuttisia ibuprofeenikoostumuksia | |
| MX11584A (es) | Composiciones farmaceuticas | |
| FI934387A0 (fi) | 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner | |
| BR9304405A (pt) | Composição contendo carbonila | |
| DK0599461T3 (da) | Hærdelige sammensætninger | |
| FI920845A (fi) | Farmaceutiska kompositioner innehaollande interleukin-2 | |
| ITMI922580A1 (it) | Composizione farmaceutica | |
| ITMI922581A1 (it) | Composizione farmaceutica | |
| SE9202820D0 (sv) | Farmaceutisk komposition |